Predictors of Antivenom Administration and Dose Requirement among Snakebite Patients: A Prospective Observational Study from a Tertiary Government Hospital in Tamil Nadu, India

Authors

  • Adiseshan S CRRI, Tirunelveli Medical College and Hospital, Tirunelveli, Tamil Nadu, India
  • Geetha Rani A Department of Pharmacology, Kanyakumari Medical College and Hospital, Kanyakumari, Tamil Nadu, India
  • Meenakumari Department of General Medicine, Tirunelveli Medical College and Hospital, Tirunelveli, Tamil Nadu, India
  • Nisha Maheswari Y Department of Pharmacology, Tirunelveli Medical College and Hospital, Tirunelveli, Tamil Nadu, India
  • Lakshmi Prabha M Department of Pharmacology, Tirunelveli Medical College and Hospital, Tirunelveli, Tamil Nadu, India
  • Ezhil Ramya J Department of Pharmacology, Tirunelveli Medical College and Hospital, Tirunelveli, Tamil Nadu, India

DOI:

https://doi.org/10.55489/njcm.170620266224

Keywords:

Antivenoms, Predictors, Snake bite, Envenomation

Abstract

Background: Snakebite envenoming is a neglected tropical disease-causing significant mortality and morbidity globally. Considerable variability exists in antivenom administration practices. This study aimed to identify predictors of anti-snake venom (ASV) administration and dose requirements among snakebite patients.

Methods: A prospective observational study was conducted at a tertiary government hospital in Tirunelveli, Tamil Nadu, over two months (October–November 2022). A total of 139 patients admitted to intensive care units with snakebite history were enrolled using consecutive sampling. Bivariate and multivariate logistic and linear regression analyses were performed to identify predictors of ASV use and dosing.

Results: ASV was administered to 82 (58.9%) patients. Snake identification (AOR=4.95; p=0.007) and pain at bite site (AOR=2.81; p=0.017) were independent predictors of ASV administration. Bleeding at the bite site (β=0.592; p=0.021), lymphadenopathy (β=0.544; p=0.037), and neurotoxic envenomation (β=-0.861; p=0.005) were significant predictors of higher ASV dose requirements. Mortality was nil and adverse reactions were mild (9.7%).

Conclusion: Snake identification and pain at bite site predict ASV administration, while bleeding, lymphadenopathy, and envenomation type determine dose requirements, enabling rational, protocol-driven antivenom use.

References

National Health Mission, Ministry of Health and Family Welfare, Government of India. Management of snake bite: full background document. New Delhi: NHM; 2016. Available from: https://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/stg/Snakebite_Full.pdf [Accessed on 2025 Oct 10]

World Health Organization. Snakebite envenoming [Internet]. Geneva: WHO; 2023 Sep 12 [cited 2025 Nov 12]. Available from: https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming

Ralph R, Sharma SK, Faiz MA, Ribeiro I, Rijal S, Chappuis F, Kuch U. The timing is right to end snakebite deaths in South Asia. BMJ. 2019 Jan 22;364:k5317. DOI: https://doi.org/10.1136/bmj.k5317 PMid:30670457 PMCid:PMC6340368

Centre for One Health, National Centre for Disease Control, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. National Action Plan for the Prevention and Control of Snakebite Envenoming (NAPSE) [Internet]. New Delhi: Government of India; 2024 [cited 2025 Nov 12]. Available from: https://ncdc.mohfw.gov.in/wp-content/uploads/2024/07/NATIONAL-ACTION-PLAN-FOR-PREVENTION-AND-CONTROL-OF-SNAKEBITE-ENVENOMING-NAPSE.pdf

Salve PS, Vatavati S, Hallad J. Clustering the envenoming of snakebite in India: the district level analysis using Health Management Information System data. Clinical epidemiology and global health. 2020 Sep 1;8(3):733-738. DOI: https://doi.org/10.1016/j.cegh.2020.01.011

National Health Mission, Tamil Nadu. Integrated Disease Surveillance Programme (IDSP): Annual report on snakebite envenomation. Chennai: State Surveillance Unit; 2024.

Ojha A, Hadimani P, Anthony D, Raj V, Bhasker S, Mishra M, Johri S. Optimizing Anti-Snake Venom Strategies for Hemotoxic Envenomation in Northern India: Clinical Outcomes and Regional Challenge. Cureus. 2025 May 14;17(5):e84090. DOI: https://doi.org/10.7759/cureus.84090 PMID: 40519476 PMCID: PMC12164467

Pore SM, Ramanand SJ, Patil PT, Gore AD, Pawar MP, Gaidhankar SL, et al. A retrospective study of use of polyvalent anti-snake venom and risk factors for mortality from snake bite in a tertiary care setting. Indian J Pharmacol. 2015 May-Jun;47(3):270-274. DOI: https://doi.org/10.4103/0253-7613.157117 PMid:26069363 PMCid:PMC4450551

Saravu K, Somavarapu V, Shastry AB, Kumar R. Clinical profile, species-specific severity grading, and outcome determinants of snake envenomation: An Indian tertiary care hospital-based prospective study. Indian J Crit Care Med. 2012 Oct;16(4):187-192. DOI: https://doi.org/10.4103/0972-5229.106499 PMid:23559724 PMCid:PMC3610449

World Health Organization, Regional Office for South-East Asia. Guidelines for the management of snake-bites. 2nd ed [Internet]. New Delhi: WHO Regional Office for South-East Asia; 2016 [cited 2025 Dec 12]. Available from: https://www.who.int/publications/i/item/9789290225300

Pradhan J, Majhi C, Pradhan S. A study on the clinical profile and complications of snake bite among patients at a tertiary care centre in western Odisha. Medical Journal of Dr. DY Patil University. 2023 Mar 1;16(2):151-154. DOI: https://doi.org/10.4103/mjdrdypu.mjdrdypu_422_21

Patil A, Patil LS. A study to assess the clinical profile of patients with snake bites in a tertiary care hospital. MedPulse International Journal of Medicine. September 2021;19(3):96-99. DOI: https://doi.org/10.26611/10211933

Mandal A, Chakraborty M, Iyyadurai R, Gunasekaran K. Clinical Profile, Outcome, and Cost of Care in Snakebite Patients Requiring Admissions in a Single Medical Unit: A Retrospective Study from a Tertiary Care Center in South India. Archives of Medicine and Health Sciences. 2023;11(2):190-193. DOI: https://doi.org/10.4103/amhs.amhs_51_23

Chandrakumar A, Suriyaprakash TN, Mohan PL, Thomas L, Vikas PV. Evaluation of demographic and clinical profile of snakebite casualties presented at a tertiary care hospital in Kerala. Clinical Epidemiology and Global Health. 2016 Sep 1;4(3):140-145. DOI: https://doi.org/10.1016/j.cegh.2015.12.003

Bhelkar SM, Chilkar SD, Morey SM. Study of snake bite cases admitted in tertiary care hospital in Nagpur. Int J Community Med Public Health. 2017 May;4(5):1597-1602. DOI: https://doi.org/10.18203/2394-6040.ijcmph20171770

Satyanarayan B, Panda SK, Sunder A, Kumari S. Clinical and epidemiological profile of snakebite cases - A study from an industrial teaching hospital at Jamshedpur, Jharkhand, India. J Family Med Prim Care. 2022 Dec;11(12):7652-7656. DOI: https://doi.org/10.4103/jfmpc.jfmpc_890_22 PMid:36994007 PMCid:PMC10041039

Oktay MM, Al B, Zengin S, Gümüşboğa H, Boğan M, Sabak M, Can B, Özdemir N, Eren ŞH, Yıldırım C. Snakebites on Distal Extremities; Three Years of Experiences. Zahedan Journal of Research in Medical Sciences. 2022 Jan 1;24(24):e123972. DOI: https://doi.org/10.5812/zjrms-112107

Chilakala P, Sivapackiam M, Karmegam G, Janani J. A study on the clinico-epidemiological profile of snake bite cases in an emergency department of a tertiary care hospital in Chennai. Int J Acad Med Pharm. 2023;5(4):318-323.

Maduwage K, Kodagoda Gamage S, Gutiérrez JM. First aid and pre-hospital practices in snakebite victims: The persistent use of harmful interventions. Toxicon. 2024 Feb 1;238:107582. DOI: https://doi.org/10.1016/j.toxicon.2023.107582 PMid:38128838

Patel S, Patel A, Ganjiwale J, Patel D, Nimbalkar S. The study of clinical profile and outcome of patients with snakebite in a rural community. J Family Med Prim Care. 2021 Apr;10(4):1661-1665. DOI: https://doi.org/10.4103/jfmpc.jfmpc_1976_20 PMid:34123909 PMCid:PMC8144800

Jayaraman T, Dhanasinghu R, Kuppusamy S, Gaur A, Sakthivadivel V. Bite-to-needle Time - An Extrapolative Indicator of Repercussion in Patients with Snakebite. Indian J Crit Care Med. 2022 Nov;26(11):1175-1178. DOI: https://doi.org/10.5005/jp-journals-10071-24344 PMid:36873588 PMCid:PMC9983646

Narvencar KP, Favas TT, Dias A. Predictors of complications in venomous snakebites. Indian J Med Sci 2022;74:86-92. DOI: https://doi.org/10.25259/IJMS_328_2021

Biju AP, Krishnan J. Clinical and laboratory profile of snake bite envenomation: a crosssectional observational study at a tertiary care center. J. Evid. Based Med. Healthc. 2018;5(40):2860-2864. DOI: https://doi.org/10.18410/jebmh/2018/585

Kolli Bhargavi, R M Shinde. Study the role of coagulation markers to evaluate the morbidity and mortality of snake bite victims. MedPulse International Journal of Pathology. 2023;27(3):1-5.

Moriarity RS, Dryer S, Replogle W, Summers RL. The role for coagulation markers in mild snakebite envenomations. West J Emerg Med. 2012 Feb;13(1):68-74. DOI: https://doi.org/10.5811/westjem.2011.6.6729 PMid:22461925 PMCid:PMC3298204

Bolon I, Durso AM, Botero Mesa S, Ray N, Alcoba G, Chappuis F, et al. Identifying the snake: First scoping review on practices of communities and healthcare providers confronted with snakebite across the world. PLoS One. 2020 Mar 5;15(3):e0229989. DOI: https://doi.org/10.1371/journal.pone.0229989 PMid:32134964 PMCid:PMC7058330

Kavitha S, Nalini GK, Sahana GN. Evaluation of optimum dose of anti-snake venom required and its outcome based on severity of envenomation in snakebite case. Asian Journal of Medical Sciences. 2024 Mar 1;15(3):201-206. DOI: https://doi.org/10.3126/ajms.v15i3.60323

Panwar S, Dang A. A retrospective analysis of snake envenomation in the intensive care unit of a tertiary care hospital in Delhi. Journal of Acute Disease. 2019 Jul 1;8(4):165-169. DOI: https://doi.org/10.4103/2221-6189.263710

Gamulin E, Mateljak Lukačević S, Halassy B, Kurtović T. Snake Antivenoms-Toward Better Understanding of the Administration Route. Toxins (Basel). 2023 Jun 15;15(6):398. DOI: https://doi.org/10.3390/toxins15060398 PMid:37368699 PMCid:PMC10302821

Mer RJ, Kakasaniya GG, Mehta DS. Anaphylactic Reactions After Administration of Anti Snake Venom for Envenomation: A Case Series. International Journal of Pharmaceutical and Clinical Research. 2023Oct30;15(10):503-506.

Deshpande RP, Motghare VM, Padwal SL, Pore RR, Bhamare CG, Deshmukh VS, Pise HN. Adverse drug reaction profile of anti-snake venom in a rural tertiary care teaching hospital. J Young Pharm. 2013 Jun;5(2):41-45. DOI: https://doi.org/10.1016/j.jyp.2013.02.003 PMid:24396245 PMCid:PMC3828666

Downloads

Published

2026-06-01

How to Cite

1.
Adiseshan S, Geetha Rani A, Meenakumari, Maheswari Y N, Lakshmi Prabha M, Ezhil Ramya J. Predictors of Antivenom Administration and Dose Requirement among Snakebite Patients: A Prospective Observational Study from a Tertiary Government Hospital in Tamil Nadu, India. Natl J Community Med [Internet]. 2026 Jun. 1 [cited 2026 Jun. 1];17(06):442-9. Available from: https://njcmindia.com/index.php/file/article/view/6224

Issue

Section

Original Research Articles

Similar Articles

<< < 6 7 8 9 10 11 

You may also start an advanced similarity search for this article.